Improvements based on combination with checkpoint inhibitors are also possible, as suggested by the increased expression following MEDIC cyclophosphamide treatment of both PD-1 and PD-L1 reported for other murine breast cancer models (28) and seen here in both E0771 and 4T1 tumors (Supplementary Fig. S1). This evidence concerns the gene CD274 and breast cancer.